• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 9-23 of 252,043 results

Pfenex Inc. v. GlaxoSmithKline Biologicals SA

Docket IPR2019-01478, Patent Trial and Appeal Board (Aug. 9, 2019)
Jo-Anne Kokoski, Richard Smith, Sheridan Snedden, presiding
Case TypeInter Partes Review
Patent9422345
Patent Owner GlaxoSmithKline Biologicals SA
Petitioner Pfenex Inc.
cite Cite Docket

Pfenex Inc. v. GlaxoSmithKline Biologicals SA

Docket IPR2019-01027, Patent Trial and Appeal Board (May 6, 2019)
Jo-Anne Kokoski, Richard Smith, Sheridan Snedden, presiding
Case TypeInter Partes Review
Patent9422345
Patent Owner GlaxoSmithKline Biologicals SA
Petitioner Pfenex Inc.
cite Cite Docket

Pfenex Inc. v. GlaxoSmithKline Biologicals SA

Docket IPR2019-01028, Patent Trial and Appeal Board (May 6, 2019)
Jo-Anne Kokoski, Richard Smith, Sheridan Snedden, presiding
Case TypeInter Partes Review
Patent9422345
Patent Owner GlaxoSmithKline Biologicals SA
Petitioner Pfenex Inc.
cite Cite Docket

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Docket IPR2019-00450, Patent Trial and Appeal Board (Jan. 29, 2019)
Jamie Wisz, Jon Tornquist, Zhenyu Yang, presiding
Case TypeInter Partes Review
Patent9763876
Orange Book Patent9763876
Patent Owner Neurelis, Inc.
Petitioner Aquestive Therapeutics, Inc. formerly Monosol RX, LLC
cite Cite Docket

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Docket IPR2019-00451, Patent Trial and Appeal Board (Jan. 29, 2019)

cite Cite Docket

Aquestive Therapeutics, Inc. formerly Monosol RX, LLC v. Neurelis, Inc.

Docket IPR2019-00449, Patent Trial and Appeal Board (Jan. 28, 2019)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2019-00122, Patent Trial and Appeal Board (Oct. 29, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01677, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01676, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01684, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01682, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01679, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01675, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutschland GmbH

Docket IPR2018-01696, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket

Mylan Pharmaceuticals Inc. v. Sanofi-Aventis Deutshland GmbH

Docket IPR2018-01670, Patent Trial and Appeal Board (Sept. 10, 2018)

cite Cite Docket
<< 1 2 3 4 5 ... >>